VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_18-vv-00764
Package ID: USCOURTS-cofc-1_18-vv-00764
Petitioner: Tori Dreyer
Filed: 2019-08-05
Decided: 2019-08-30
Vaccine: hepatitis B
Vaccination date: 2017-02-13
Condition: optic neuritis and/or other ophthalmological abnormalities
Outcome: dismissed
Award amount USD: 

AI-assisted case summary:
Tori Dreyer filed a petition on August 5, 2019, alleging that a hepatitis B vaccine administered on February 13, 2017, caused optic neuritis and/or other ophthalmological abnormalities. The respondent recommended against compensation. The petitioner did not allege a Table injury and therefore carried the burden to prove causation-in-fact. Following an initial status conference on May 17, 2019, during which the Special Master ordered the petitioner to file updated records and an expert report, the petitioner consulted with a neuro-ophthalmology expert. On August 2, 2019, the petitioner filed a motion to dismiss her own petition, stating that while she strongly believed the vaccine caused her visual disturbances, she could not satisfy her burden of proof in the Vaccine Program. The petitioner acknowledged that dismissal would result in a judgment against her, ending her rights in the Program, but noted she could apply for fees and costs and intended to preserve her right to file a civil action. The Special Master noted that to receive compensation, a petitioner must prove either a "Table Injury" or that the injury was caused-in-fact by a covered vaccine. The petitioner did not allege a Table injury, and the medical records did not establish causation-in-fact between the hepatitis B vaccine and her condition. Although she had consulted an expert, the expert's opinion had not been filed. Therefore, the Special Master granted the petitioner's motion to dismiss the case for insufficient proof. Judgment was entered against the petitioner. Special Master Thomas L. Gowen issued the decision on August 30, 2019. Petitioner's counsel was Andrew D. Downing, and respondent's counsel was Mollie D. Gorney.

Theory of causation field:
Petitioner Tori Dreyer alleged that a hepatitis B vaccine administered on February 13, 2017, caused optic neuritis and/or other ophthalmological abnormalities. The case was filed on August 5, 2019. The petitioner did not allege a Table injury and thus had the burden to prove causation-in-fact. The petitioner consulted with a neuro-ophthalmology expert but did not file the expert's opinion. The medical records did not establish causation-in-fact. The petitioner moved to dismiss her petition for insufficient proof, which was granted by Special Master Thomas L. Gowen on August 30, 2019. The case was dismissed for insufficient proof, with judgment entered against the petitioner. Petitioner's counsel was Andrew D. Downing, and respondent's counsel was Mollie D. Gorney.

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_18-vv-00764-0
Date issued/filed: 2019-08-30
Pages: 2
Docket text: PUBLIC DECISION (Originally filed: 8/5/19) regarding 31 DECISION of Special Master. Signed by Special Master Thomas L. Gowen. (kb) Service on parties made.
--------------------------------------------------------------------------------
Case 1:18-vv-00764-UNJ Document 39 Filed 08/30/19 Page 1 of 2
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
Filed: August 5, 2019
* * * * * * * * * * * * *
TORI DREYER, * UNPUBLISHED
*
Petitioner, * No. 18-764V
*
v. * Special Master Gowen
*
SECRETARY OF HEALTH * Motion for Dismissal Decision;
AND HUMAN SERVICES, * Hepatitis B (“Hep B”); Optic
* Neuritis.
Respondent. *
* * * * * * * * * * * * *
Andrew D. Downing, Van Cott & Talamante, PLLC, Phoenix, AZ, for petitioner.
Mollie D. Gorney, United States Department of Justice, Washington, DC, for respondent.
DECISION1
On May 31, 2018, Tori Dreyer (“petitioner”) filed a petition in the National Vaccine
Injury Compensation Program.2 Petition (ECF No. 1). Petitioner alleged that as a result of an
hepatitis B (“Hep B”) vaccine received on February 13, 2017, she developed an adverse reaction,
namely optic neuritis and/or other ophthalmological abnormalities. Id. at 1, 7. On April 19,
2019, respondent filed his report pursuant to Vaccine Rule 4(c), in which respondent
recommended against compensation. Respondent’s Report (“Resp. Rep’t”) (ECF No. 23). On
May 17, 2019, I held an initial status conference during which I ordered petitioner to file updated
records and an expert report in support of her claim.
1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this opinion contains a
reasoned explanation for the action in this case, I am required to post it on the website of the United States Court of
Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. This means the
opinion will be available to anyone with access to the Internet. Before the decision is posted on the court’s
website, each party has 14 days to file a motion requesting redaction “of any information furnished by that party:
(1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that
includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of
privacy.” Vaccine Rule 18(b). An objecting party must provide the court with a proposed redacted version of the
opinion. Id. If neither party files a motion for redaction within 14 days, the opinion will be posted on the
court’s website without any changes. Id.
2 The Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, 42 U.S.C. §§ 300aa-10 et
seq. (hereinafter “Vaccine Act” or “the Act”). Hereafter, individual section references will be to 42 U.S.C. § 300aa
of the Act.

Case 1:18-vv-00764-UNJ Document 39 Filed 08/30/19 Page 2 of 2
On August 2, 2019, petitioner filed a motion for a decision dismissing the petition.
Petitioner’s Motion (“Pet. Mot.”) (ECF No. 30). She provides that her workers’ compensation
claim, her employer’s filing of a VAERS report, and her medical records support her position.
Id. at 1-2. She has had the opportunity to consult with a neuro-ophthalmology expert. Id. at 2.
“Although petitioner feels very strongly about vaccination as the cause of her visual
disturbances, it does not appear at this juncture that petitioner can satisfy her burden of proof in
the Vaccine Program to establish entitlement. Under these circumstances, to proceed further
would be unreasonable and would waste the resources of the Court, the Respondent, and the
Vaccine Program.” Id. Petitioner understands that a decision by the special master dismissing
her petition will result in a judgment against her and that such a judgment will end all of his
rights in the Vaccine Program. Id. Petitioner understands that she may apply for fees and costs
once the case is dismissed and judgment is entered against her. Id. Petitioner intends to protect
her rights to file a civil action in the future. Therefore, pursuant to Section 21(a)(2), petitioner
intends to elect to reject the Vaccine Program judgment and elect to file a civil action at the
appropriate time. Id. at ¶ 6.
To receive compensation in the Vaccine Program, petitioner must prove either: (1) that
she suffered a “Table Injury,” i.e., an injury beginning within a specified period of time
following receipt of a corresponding vaccine listed on the Vaccine Injury Table, or (2) that she
suffered an injury that was caused-in-fact by a covered vaccine. §§ 13(a)(1)(A); 11(c)(1).
Additionally, under the Vaccine Act, the Vaccine Program may not award compensation solely
based on a petitioner’s own claims. Rather, a petitioner must support the claim with either
medical records or the opinion of a competent physician. § 13(a)(1). In this case, petitioner does
not allege and the record does not identify the existence of a Table injury. Therefore, petitioner
has the burden of establishing causation-in-fact. The medical records do not establish causation-
in-fact between the Hep B vaccine and petitioner’s optic neuritis and/or other ophthalmological
abnormalities. Petitioner has consulted with a neuro-ophthalmology expert but has not filed their
opinion. Accordingly, at this juncture, petitioner has not met her burden of proof.
Thus, petitioner’s motion is GRANTED. This matter is DISMISSED for insufficient
proof. The Clerk of the Court shall enter judgment accordingly.3
IT IS SO ORDERED.
s/Thomas L. Gowen
Thomas L. Gowen
Special Master
3 Entry of judgment is expedited by each party’s filing notice renouncing the right to seek review. Vaccine Rule
11(a).
2